Abstract: A soluble fiber lozenge provided herein includes a body that is partially or wholly receivable in an oral cavity. The body includes a soluble-fiber matrix and one or more additives dispersed in the soluble-fiber matrix. In some cases, a soluble fiber lozenge provided herein includes at least 40 weight percent of soluble fiber. In some cases, soluble fiber in soluble fiber lozenge provided herein can include maltodextrin. The soluble fiber lozenge is adapted to release one or more additives from the body when the body is received within the oral cavity of a consumer and exposed to saliva. A method of making soluble fiber lozenges provided herein includes forming a molten mixture of at least 40 weight percent soluble fiber, one or more additives, and less than 15 weight percent water while maintaining a mixture temperature of less than 200° C. and portioning the molten mixture into a plurality of soluble fiber lozenges. In some cases, the ingredients can be mixed to form the molten mixture in an extruder.

Abstract: An oral product includes a body that is wholly receivable in an oral cavity. The body includes a mouth-stable polymer matrix, cellulosic fibers embedded in the mouth-stable polymer matrix, and an additive dispersed in the mouth-stable polymer matrix. The oral product is adapted to release the additive from the body when the body is received within the oral cavity and exposed to saliva.

Abstract: An oral tobacco product includes a body that is wholly receivable in an oral cavity. The body includes a mouth-stable polymer matrix and tobacco fibers embedded in the mouth-stable polymer matrix. The oral tobacco product can be formed by extruding a mixture of mouth-stable polymer and tobacco fibers.

Abstract: A method and system can be used for disease quantification modeling of an anatomical tree structure. The method may include obtaining a centerline of an anatomical tree structure and generating a graph neural network including a plurality of nodes based on a graph. Each node corresponds to a centerline point and edges are defined by the centerline, with an input of each node being a disease related feature or an image patch for the corresponding centerline point and an output of each node being a disease quantification parameter. The method also includes obtaining labeled data of one or more nodes, the number of which is less than a total number of the nodes in the graph neural network. Further, the method includes training the graph neural network by transferring information between the one or more nodes and other nodes based on the labeled data of the one or more nodes.

Abstract: A high temperature resistant wire is provided. The high temperature resistant wire comprises a carbon nanotube wire and a boron nitride layer coated on a surface of the carbon nanotube wire. The boron nitride layer is coaxially arranged with the carbon nanotube wire. A working temperature of the high temperature resistant wire in the air ranges from 0K to 1600K. A working temperature of the high temperature resistant wire in vacuum ranges from 0K to 2500K. A detector using the high temperature resistant wire is also provided.

Abstract: An oral product includes a body that is wholly receivable in an oral cavity. The body includes a mouth-stable polymer matrix, cellulosic fibers embedded in the mouth-stable polymer matrix, and a mouth-soluble binder dispersed in the mouth-stable polymer matrix.

Abstract: Disclosed is a method for determining a whole macro-micro process of rock deformation and failure based on a four-parameter test, including following steps: firstly, obtaining acoustic emission data and deformation data of a sample in a compression test, and then calculating the deformation data according to a finite deformation theory to obtain a mean rotation angle ? at each stress level; using Grassberger-Procaccia (G-P) algorithm to calculate the acoustic emission data, and obtaining a fractal dimension of a temporal distribution DT of an acoustic emission signal and calculating a fractal dimension of a spatial distribution DS; obtaining a microscopic morphology of a fracture surface by scanning electron microscope (SEM) test after the compression test, and calculating a fractal dimension DA of the fracture surface; finally, obtaining a mathematical trend relationship between ? and DT, DS and DA according to a comprehensive analysis of DT, DS, DA and ?.

Abstract: Embodiments of the present disclosure provide a ferromagnetic object detection device and a method for detecting a tubing coupling. The ferromagnetic object detection device includes a support tube, a magnetic field generating device and a magnetic detection device. The support tube includes a space penetrating in a first direction; the magnetic field generating device is located on an outer sidewall of the support tube and configured to generate a magnetic field; the magnetic field detection device includes a first magnetic field detection element, a second magnetic field detection element and a third magnetic field detection element.

Abstract: A display panel, a display device and a method for driving the display panel. The display panel includes: a rotation axis; at least one display area located at one side of the rotation axis; wherein the display area includes a plurality of display sub-areas; and a plurality of driving-control modules corresponding to the plurality of display sub-areas. The plurality of display sub-areas are sequentially arranged along a first direction; the first direction is directed from the rotation axis to the display area; when the display panel rotates around the rotation axis, areas passed by the plurality of display sub-areas form a plurality of imaging sub-areas. The plurality of driving-control modules are configured to control the plurality of display sub-areas to have different display parameters, respectively, thereby enabling imaging brightness of the plurality of imaging sub-areas to be within a preset brightness range.

Abstract: The present invention discloses an aspheric lens eccentricity detecting device based on wavefront technology and a detecting method thereof. The device comprises: an upper optical fiber light source, an upper collimating objective lens, an upper light source spectroscope, an upper beam-contracting front lens, an upper beam-contracting rear lens, an upper imaging detector, an upper imaging spectroscope, an upper wavefront sensor, a lens-under-detection clamping mechanism, a lower light source spectroscope, a lower beam-contracting front lens, a lower beam-contracting rear lens, a lower imaging spectroscope, a lower wavefront sensor, a lower imaging detector, a lower collimating objective lens and a lower optical fiber light source.

Abstract: The disclosure relates to the field of ocean engineering technical equipment, and specifically relates to a seabed geotechnical in-situ multi-parameter detection system and method.

Abstract: A display device, a method for driving the same, and a display system are provided. In the display device, a drive circuit can first drive the display panel to display a target image containing a number of colors less than a number threshold in response to detecting that a host computer stops delivering image data (i.e., the screen is turned off), and then drive the display panel to enter a standby state. In this way, the display panel can be made to stably transition to the standby state upon screen-off of the host computer, thereby solving the problems of stalled display or abnormal display caused by the display panel being unable to enter the standby state reliably.

Abstract: A crystalline form of CXCR2 antagonist, such as Compound 1, is used in preparing a drug for treating CXCR2-related diseases.

Abstract: An oral pouch product includes an outer wrapper defining a cavity and an inner filling material in the cavity. The outer wrapper includes a hydrophobic material or an elastomeric material. The inner filling material includes a dry mixture and a liquid mixture. The dry mixture includes a cellulosic material. The liquid mixture includes a triglyceride and liquid nicotine dissolved in the triglyceride. The triglyceride is included in the oral pouch product in an amount of 10% to 30% by weight based on the weight of the oral pouch product.

Abstract: At least one example embodiment relates to an oral product. In at least one example embodiment, the oral product comprises a liquid mixture. The liquid mixture includes a triglyceride and liquid nicotine dissolved in the triglyceride. At least a portion of the liquid nicotine is free-base nicotine. A weight ratio of the triglyceride to the liquid nicotine in the liquid mixture ranges from 1:1 to 9:1. At least one example embodiment relates to a method of increasing buccal absorption of nicotine in an oral product.

Abstract: An apparatus for forming a nicotine gum may include a first pair of drums configured to receive and press a nicotine gum mixture to a first thickness so as to form a first pressed sheet and a second pair of drums configured to receive and score the first pressed sheet so as to form a scored sheet including a plurality of gum pieces. The second pair of drums may include a first drum having a first die with a first pattern and a second drum having a second die with a second pattern. The second pattern may be a mirror image of the first pattern. The first drum and the second drum may be spaced such that as the first pressed sheet passes between the first drum and the second drum, the first die and the second die at least score the first pressed sheet.

Abstract: A method for forming encapsulated sweetener granules (ESGs) may include heating a first mixture to form a molten mixture, the first mixture includes one or more polyols and one or more hydrocolloids; cooling the molten mixture to a first temperature to form a cooled molten mixture; adding one or more high-intensity sweeteners to the cooled molten mixture to form a second mixture; cooling the second mixture to a second temperature to form one or more sheets, the second temperature being different from the first temperature; and fragmenting the one or more sheets to form a plurality of encapsulated sweetener granules. The first temperature may be between about 120° C. and about 200° C. The second temperature may be below a glass transition temperature (Tg) of the one or more polyols and the one or more hydrocolloids. For example, the second temperature may be between about 65° C. and about 200° C.

Abstract: At least one example embodiment relates to a chewing gum. In at least one example embodiment, the chewing gum comprises a gum base polymer and oil. The gum base polymer includes polyvinyl acetate (PVA) in an amount ranging from 35 weight percent to 55 weight percent of the chewing gum. The oil is present in an amount greater than 8 weight percent of the chewing gum. The oil includes a triglyceride, triacetin, and nicotine or a nicotine derivative. The triglyceride is present in an amount greater than or equal to 5 weight percent of the chewing gum. At least one example embodiment relates to a method of preparing a controlled-release nicotine chewing gum.

Abstract: A method for forming encapsulated nicotine granules (ENGs) includes heating a first mixture to form a molten mixture, the first mixture includes one or more polyols; cooling the molten mixture to a first temperature to form a cooled molten mixture; adding at least one of nicotine and one or more nicotine salts to the cooled molten mixture to form a second mixture; cooling the second mixture to a second temperature to form one or more solidified structures, where the second temperature is different from the first temperature; and fragmenting the one or more solidified structures so as to form a plurality of encapsulated nicotine granules. The first temperature may be between about 120° C. and about 200° C. The second temperature may be below a glass transition temperature (Tg) of the one or more polyols. For example, the second temperature may be between about 65° C. and about 200° C.

Abstract: A method and system can be used for disease quantification modeling of an anatomical tree structure. The method may include obtaining a centerline of an anatomical tree structure and generating a graph neural network including a plurality of nodes based on a graph. Each node corresponds to a centerline point and edges are defined by the centerline, with an input of each node being a disease related feature or an image patch for the corresponding centerline point and an output of each node being a disease quantification parameter. The method also includes obtaining labeled data of one or more nodes, the number of which is less than a total number of the nodes in the graph neural network. Further, the method includes training the graph neural network by transferring information between the one or more nodes and other nodes based on the labeled data of the one or more nodes.